Valve Durability in TAVR is a Critical Factor for the Future

Aortic stenosis continues to be a major global healthcare issue, affecting 62 million people over the age of 65 years worldwide. Driving earlier intervention is a key focus for healthcare providers and policy makers. Consequently, the market for Aortic Valve Replacement (mainly Transcatheter Heart Valves) is expected to grow substantially over the coming years, rising from US$6 billion today to an estimated $US7 billion by 2025.